Vancomycin
- Generic Name
- Vancomycin
- Brand Names
- Firvanq, Vancocin
- Drug Type
- Small Molecule
- Chemical Formula
- C66H75Cl2N9O24
- CAS Number
- 1404-90-6
- Unique Ingredient Identifier
- 6Q205EH1VU
- Background
Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to ristocetin that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
...
- Indication
Administered intravenously, vancomycin is indicated in adult and pediatric patients for the treatment of septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections. Administered orally, vancomycin is indicated in adult and pediatric patients for the treatment of Clostridium difficile-associ...
- Associated Conditions
- Clostridium Difficile Associated Diarrhea (CDAD), Enterocolitis caused by Staphylococcus aureus, Infection caused by staphylococci, Severe Staphylococcal infection
- Associated Therapies
- -
A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia
- Conditions
- Interventions
- First Posted Date
- 2022-02-04
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- LigaChem Biosciences, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT05225558
- Locations
- 🇰🇷
Korea University Ansan Hospital, Ansan, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Seoul, Korea, Republic of
🇰🇷Severance Hospital, Seoul, Korea, Republic of
Staphylococcus Aureus Network Adaptive Platform Trial
- First Posted Date
- 2021-11-30
- Last Posted Date
- 2024-06-05
- Lead Sponsor
- University of Melbourne
- Target Recruit Count
- 8000
- Registration Number
- NCT05137119
- Locations
- 🇦🇺
Cairns Hospital, Cairns, Queensland, Australia
🇨🇦Hôpital Régional de Saint Jérôme, Saint-Jérôme, Quebec, Canada
🇳🇱Jeroen Bosch Hospital, 's-Hertogenbosch, Netherlands
Early Antibiotics After Aspiration in ICU Patients
- Conditions
- Interventions
- First Posted Date
- 2021-10-15
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- UConn Health
- Target Recruit Count
- 5
- Registration Number
- NCT05079620
- Locations
- 🇺🇸
UConn Health, John Dempsey Hospital, Farmington, Connecticut, United States
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
- First Posted Date
- 2021-07-30
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT04983901
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)
- Conditions
- Interventions
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2024-02-26
- Lead Sponsor
- Ari M Grinspan
- Target Recruit Count
- 4
- Registration Number
- NCT04968951
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Application of Fecal Microbiota Transplantation in Children With ASD
- Conditions
- Interventions
- First Posted Date
- 2021-07-02
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT04948814
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
To Assess Use of Vancomycin Powder in Craniotomy on Wound Infection Rates
- First Posted Date
- 2021-06-08
- Last Posted Date
- 2021-06-08
- Lead Sponsor
- Hamad General Hospital
- Target Recruit Count
- 500
- Registration Number
- NCT04917627
- Locations
- 🇶🇦
Hamad General Hospital, Doha, Qatar
Acute Application of Antibiotic Powder in Open Fracture Wounds
- First Posted Date
- 2021-05-04
- Last Posted Date
- 2024-02-05
- Lead Sponsor
- University of Colorado, Denver
- Target Recruit Count
- 20
- Registration Number
- NCT04872400
- Locations
- 🇺🇸
University of Colorado Anschutz, Aurora, Colorado, United States
🇺🇸Denver Health and Hospital Authority, Denver, Colorado, United States
Effect of Vancomycin After Catheter Replacement
- Conditions
- Interventions
- First Posted Date
- 2021-04-23
- Last Posted Date
- 2021-04-29
- Lead Sponsor
- University of Zurich
- Target Recruit Count
- 100
- Registration Number
- NCT04856878
The Effect of Intrawound Vancomycin Powder in Spine Surgery
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2024-04-23
- Lead Sponsor
- Windsor-Essex Compassionate Care Community
- Target Recruit Count
- 1643
- Registration Number
- NCT04825522
- Locations
- 🇪🇬
Cairo University Hospitals, Cairo, Egypt
🇨🇦Windsor Regional Hospital - Ouellette, Windsor, Ontario, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.